SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 3,459.38 |
| Enterprise Value ($M) | 3,233.71 |
| Book Value ($M) | 1,939.66 |
| Book Value / Share | 22.73 |
| Price / Book | 1.78 |
| NCAV ($M) | 1,627.42 |
| NCAV / Share | 19.07 |
| Price / NCAV | 2.13 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.11 |
| Return on Assets (ROA) | -0.11 |
| Return on Equity (ROE) | -0.13 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 21.64 |
| Current Ratio | 21.64 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,943.89 |
| Assets | 2,256.13 |
| Liabilities | 316.47 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | ARK Investment Management LLC | 10.69 | 6.87 | |
| 13G/A | Capital International Investors | 10.20 | 28.08 | |
| 13G/A | Nikko Asset Management Americas, Inc. | 4.24 | -15.89 | |
| 13G/A | Sumitomo Mitsui Trust Holdings, Inc. | 4.24 | -15.89 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 362,493 | 1,662,064 | 21.81 | |
| 309,046 | 1,235,430 | 25.02 | |
| 320,620 | 1,354,642 | 23.67 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CMRX – Chimerix, Inc. | CRMD – CorMedix Inc. |
| CRON – Cronos Group Inc. | CRVS – Corvus Pharmaceuticals, Inc. |
| CURR – CURRENC Group Inc. |
Financial data and stock pages provided by
Fintel.io